more

Phibro Animal Health (PAHC)

(Delayed Data from NSDQ)

$18.40 USD

+0.42 (2.34%)

Updated May 17, 2024 04:00 PM ET

After-Market: $18.38 -0.02 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

Bottom 42% (145 out of 249)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Add Tandem Diabetes to Your Portfolio

by Zacks Equity Research Published on April 21,2020

Investors continue to be optimistic about Tandem Diabetes (TNDM) on its strength in the diabetes business and receipt of regulatory approvals.

Walgreens' Retail Pharmacy Grows Amid Coronavirus Crisis

by Zacks Equity Research Published on April 20,2020

Walgreens (WBA) registers growing demand for Retail Pharmacy & Pharmaceutical Wholesale products in Q2.

medical

Abbott Launches Antibody Test to Detect Coronavirus Infection

by Zacks Equity Research Published on April 20,2020

Abbott (ABT) launches a lab-based serology blood test to detect the presence of antibodies post the coronavirus infection.

medical

QIAGEN Launches Assay for Cancer Patients Following FDA's Nod

by Zacks Equity Research Published on April 17,2020

QIAGEN (QGEN) paves the way for metastatic CRC treatment in adults with the launch of an FDA-approved companion diagnostic test kit.

NuVasive (NUVA) Posts Q1 Preliminary Results, Withdraws View

by Zacks Equity Research Published on April 16,2020

A decline in elective surgical procedures due to coronavirus outbreak weighs on NuVasive's (NUVA) preliminary revenue results for first-quarter 2020.

medical

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

by Zacks Equity Research Published on April 15,2020

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PAHCPositive Net Change

QIAGEN (QGEN) Reports Preliminary Revenue Results for Q1

by Zacks Equity Research Published on April 15,2020

Investors remain optimistic with QIAGEN's (QGEN) first-quarter 2020 preliminary revenue results, which is likely to benefit from increased testing demand for coronavirus infection.

medical

Illumina (ILMN) Posts Q1 Preliminary Results, Withdraws View

by Zacks Equity Research Published on April 15,2020

Investors remain optimistic on Illumina's (ILMN) strong preliminary revenue results for first-quarter 2020.

medical

Here's Why You Should Add ResMed (RMD) in Your Portfolio

by Zacks Equity Research Published on April 14,2020

Investors continue to be optimistic about ResMed (RMD) on its focus on digital health technology and combatting the coronavirus outbreak.

medical

Integra Releases Preliminary Q1 Results, Withdraws '20 View

by Zacks Equity Research Published on April 08,2020

Integra (IART) unable to measure the magnitude of total loss it has to bear out of the coronavirus-led economic damages, and hence, withdraws the full-year guidance.

medical

Medtronic (MDT) Demonstrates Global Growth Amid Cost Concerns

by Zacks Equity Research Published on April 08,2020

Medtronic's (MDT) international Diabetes business registers solid growth on the continued adoption of MiniMed 670G in overseas markets.

medical

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

by Zacks Equity Research Published on April 07,2020

Investors continue to be optimistic about Thermo Fisher (TMO) on its strong segmental growth in the fourth quarter of 2019.

medical

Product Launches Aid Hill-Rom Amid Project Timing Issues

by Zacks Equity Research Published on April 07,2020

Hill-Rom (HRC) plans to roll out five-six new products each year through 2022.

medical

Here's Why You Should Add STERIS (STE) Stock in Your Portfolio

by Zacks Equity Research Published on April 06,2020

Investors continue to be optimistic about STERIS (STE) on its strong segmental growth in the third quarter of 2020.

medical

Haemonetics (HAE) Buys enicor to Expand Testing Portfolio

by Zacks Equity Research Published on April 06,2020

Haemonetics (HAE) expands its portfolio with the buyout of enicor. With the latter's whole blood coagulation testing system, the company will address a wider range of criticalities in medicine.

medical

Align Technology Buys exocad to Expand Its Digital Platform

by Zacks Equity Research Published on April 03,2020

Align Technology (ALGN) expands its portfolio with the buyout completion of exocad. This will help the company offer fully integrated workflows to dental labs and dental practices worldwide.